Biotech Stock News Bite - Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update
Biotech Stock News Bite - Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update
Stay updated with breaking news from Immunic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotech Stock News Bite - Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update
Immunic (NASDAQ:IMUX – Get Free Report) will be announcing its earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of ($0.51) per share for the quarter. Immunic (NASDAQ:IMUX – Get Free Report) last released its earnings results on Tuesday, November 14th. The company reported ($0.51) EPS for […]
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for shares of Immunic in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.66) per share for the year. The consensus estimate […]
NEW YORK, Feb. 1, 2024 /PRNewswire/ -- Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and...
Immunic, Inc. (NASDAQ:IMUX – Get Free Report) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,260,000 shares, an increase of 48.2% from the December 31st total of 2,200,000 shares. Based on an average daily volume of 768,700 shares, the days-to-cover ratio is […]